FdaApplication
ANDA 211227
Identifiers
- fda_app_no: ANDA211227
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2024-02-27 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 600MG | TABLET;ORAL |
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 200MG | TABLET;ORAL |
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 400MG | TABLET;ORAL |
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 800MG | TABLET;ORAL |
4 products